{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:54:09Z","timestamp":1781272449844,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11274-014-1739-4","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T11:03:47Z","timestamp":1410779027000},"page":"3121-3128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Synergistic interaction of PMAP-36 and PRW4 with aminoglycoside antibiotics and their antibacterial mechanism"],"prefix":"10.1007","volume":"30","author":[{"given":"Zeyun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,16]]},"reference":[{"key":"1739_CR1","volume-title":"Goodman and Golman\u2019s: the pharmacological basis of therapeutic","author":"LZ Benet","year":"1996","unstructured":"Benet LZ, Kroetz DL, Sheiner LB et al (1996) Goodman and Golman\u2019s: the pharmacological basis of therapeutic. McGraw-Hill, New York"},{"key":"1739_CR2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238\u2013250","journal-title":"Nat Rev Microbiol"},{"key":"1739_CR3","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.1074\/jbc.M413406200","volume":"280","author":"Y Chen","year":"2005","unstructured":"Chen Y, Mant CT, Farmer SW et al (2005) Rational design of \u03b1-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index. J Biol Chem 280:12316\u201312329","journal-title":"J Biol Chem"},{"key":"1739_CR4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1128\/AAC.00925-06","volume":"51","author":"YX Chen","year":"2007","unstructured":"Chen YX, Michael T, Guarnieri AI et al (2007) Role of peptide hydrophobicity in the mechanism of action of \u03b1-helical antimicrobial peptides. Antimicrob Agents Chemother 51:1398\u20131406","journal-title":"Antimicrob Agents Chemother"},{"key":"1739_CR5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0196-9781(00)00254-0","volume":"21","author":"AGO Cirioni","year":"2000","unstructured":"Cirioni AGO, Prete MSD, Paggi AM, D\u2019Errico MM, Scalise G (2000) Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria. Peptides 21:1155\u20131160","journal-title":"Peptides"},{"key":"1739_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-5793(94)00621-0","volume":"349","author":"I Cornut","year":"1994","unstructured":"Cornut I, B\u00fcttner K, Dasseaux JL, Dufourcq J (1994) The amphipathic \u03b1-helix concept: application to the de novo design of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than melittin. FEBS Lett 349:29\u201333","journal-title":"FEBS Lett"},{"key":"1739_CR7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0014-5793(97)00055-0","volume":"403","author":"M Dathe","year":"1997","unstructured":"Dathe M, Wieprecht T, Nikolenko H et al (1997) Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett 403:208\u2013212","journal-title":"FEBS Lett"},{"key":"1739_CR8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0014-5793(01)02648-5","volume":"501","author":"M Dathe","year":"2001","unstructured":"Dathe M, Nikolenko H, Meyer J, Beyermann M, Bienert M (2001) Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett 501:146\u2013150","journal-title":"FEBS Lett"},{"key":"1739_CR9","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/S0021-9258(18)93308-9","volume":"243","author":"J Davis","year":"1968","unstructured":"Davis J, Davis BD (1968) Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics. J Biol Chem 243:3312\u20133316","journal-title":"J Biol Chem"},{"key":"1739_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0005-2736(99)00198-4","volume":"1462","author":"RM Epand","year":"1999","unstructured":"Epand RM, Vogel HJ (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462:11\u201328","journal-title":"Biochim Biophys Acta"},{"key":"1739_CR11","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1128\/AAC.43.7.1542","volume":"43","author":"C Friedrich","year":"1999","unstructured":"Friedrich C, Scott MG, Karunaratne N, Yan H, Hancock RE (1999) Salt-resistant \u03b1-helical cationic antimicrobial peptides. Antimicrob Agents Chemother 43:1542\u20131548","journal-title":"Antimicrob Agents Chemother"},{"key":"1739_CR12","volume-title":"Goodman and Golman\u2019s: the pharmacological basis of therapeutics","author":"AG Gilman","year":"1990","unstructured":"Gilman AG, Rall TW, Nies AS et al (1990) Goodman and Golman\u2019s: the pharmacological basis of therapeutics. Pergomon Press, Elmsford"},{"key":"1739_CR13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4314\/tjpr.v9i3.56284","volume":"9","author":"S Hadji-nejad","year":"2010","unstructured":"Hadji-nejad S, Rahbarand M, Mehrgan H (2010) Synergy between phenothiazines and oxacillin against clinical isolates of methicillin-resistant Staphylococcus aureus. Trop J Pharm Res 9:243\u2013249","journal-title":"Trop J Pharm Res"},{"key":"1739_CR14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-7012(00)00241-4","volume":"44","author":"B Herigstad","year":"2001","unstructured":"Herigstad B, Hamilton M, Heersink J (2001) How to optimize the drop plate method for enumerating bacteria. J Microbiol Methods 44:121\u2013129","journal-title":"J Microbiol Methods"},{"key":"1739_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jhin.2009.11.021","volume":"75","author":"TS Jacoby","year":"2010","unstructured":"Jacoby TS, Kuchenbecker RS, Dos Santos RP et al (2010) Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit. J Hosp Infect 75:23\u201327","journal-title":"J Hosp Infect"},{"key":"1739_CR16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","volume":"48","author":"MD Johnson","year":"2004","unstructured":"Johnson MD, MacDougall C, Zeichner LO, Perfect JR, Rex JH (2004) Combination antifungal therapy. Antimicrob Agents Chemother 48:693\u2013715","journal-title":"Antimicrob Agents Chemother"},{"key":"1739_CR17","doi-asserted-by":"crossref","first-page":"15610","DOI":"10.1021\/bi048206q","volume":"43","author":"S Kobayashi","year":"2004","unstructured":"Kobayashi S, Chikushi A, Tougu S et al (2004) Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry 43:15610\u201315616","journal-title":"Biochemistry"},{"key":"1739_CR18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0025-7125(16)30038-4","volume":"79","author":"O Lortholary","year":"1995","unstructured":"Lortholary O, Tod M, Cohen Y, Petitjean O (1995) Aminoglycosides. Med Clin North Am 79:761\u2013798","journal-title":"Med Clin North Am"},{"key":"1739_CR19","author":"YF Lv","year":"2014","unstructured":"Lv YF, Wang JJ, Gao H et al (2014) Antimicrobial properties and membrane-active mechanism of a potential \u03b1-helical antimicrobial derived from cathelicidin PMAP-36. PLoS One. doi: 10.1371\/journal.pone.0086364","journal-title":"PLoS One"},{"key":"1739_CR20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00726-012-1457-x","volume":"44","author":"QQ Ma","year":"2013","unstructured":"Ma QQ, Lv YF, Gu Y et al (2013) Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat. Amino Acids 44:1215\u20131224","journal-title":"Amino Acids"},{"key":"1739_CR21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.resmic.2011.02.005","volume":"162","author":"G Maroti","year":"2011","unstructured":"Maroti G, Kereszt A, Kondorosi E, Mergaert P (2011) Natural roles of antimicrobial peptides in microbes, plants and animals. Res Microbiol 162:363\u2013374","journal-title":"Res Microbiol"},{"key":"1739_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13693780410001731547","volume":"43","author":"JJW Meletiadis","year":"2005","unstructured":"Meletiadis JJW, Mouton DTA, Dorsthorst T, Verweij PE (2005) Assessing combination of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models. Med Mycol 43:133\u2013152","journal-title":"Med Mycol"},{"key":"1739_CR23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S002217240001158X","volume":"38","author":"AA Miles","year":"1938","unstructured":"Miles AA, Misra SS (1938) The estimation of the bactericidal power of the blood. J Hyg 38:732\u2013749","journal-title":"J Hyg"},{"key":"1739_CR24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/JCM.43.1.140-143.2005","volume":"43","author":"G Orhan","year":"2005","unstructured":"Orhan G, Bayram A, Zer Y, Balci I (2005) Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol 43:140\u2013143","journal-title":"J Clin Microbiol"},{"key":"1739_CR25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/bbrc.1998.8159","volume":"244","author":"CB Park","year":"1998","unstructured":"Park CB, Kim HS, Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244:253\u2013257","journal-title":"Biochem Biophys Res Commun"},{"key":"1739_CR26","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1021\/bi800991e","volume":"47","author":"M Pasupuleti","year":"2008","unstructured":"Pasupuleti M, Walse B, Svensson B, Malmsten M, Schmidtchen A (2008) Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. Biochemistry 47:9057\u20139070","journal-title":"Biochemistry"},{"key":"1739_CR27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/07388551.2011.594423","volume":"32","author":"M Pasupuleti","year":"2012","unstructured":"Pasupuleti M, Schmidtchen A, Malmsten M (2012) Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol 32:143\u2013171","journal-title":"Crit Rev Biotechnol"},{"key":"1739_CR28","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1111\/j.1742-4658.2005.04852.x","volume":"272","author":"M Scocchi","year":"2005","unstructured":"Scocchi M, Zelezetsky I, Benincasa M et al (2005) Structural aspects and biological properties of the cathelicidin PMAP-36. FEBS J 272:4398\u20134406","journal-title":"FEBS J"},{"key":"1739_CR29","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/IAI.67.4.2005-2009.1999","volume":"67","author":"MG Scott","year":"1999","unstructured":"Scott MG, Yan H, Hancock REW (1999) Biological properties of structurally related \u03b1-helical cationic antimicrobial peptides. Infect Immun 67:2005\u20132009","journal-title":"Infect Immun"},{"key":"1739_CR30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1006\/bbrc.2001.6234","volume":"290","author":"SY Shin","year":"2002","unstructured":"Shin SY, Yang ST, Park EJ et al (2002) Salt resistance and synergistic effect with vancomycin of \u03b1-helical antimicrobial peptide P18. Biochem Biophys Res Commun 290:558\u2013562","journal-title":"Biochem Biophys Res Commun"},{"key":"1739_CR31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-5793(94)80214-9","volume":"337","author":"P Storici","year":"1994","unstructured":"Storici P, Scocchi M, Tossi A, Gennaro R, Zanetti M (1994) Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. FEBS Lett 337:303\u2013307","journal-title":"FEBS Lett"},{"key":"1739_CR32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/003655499750006236","volume":"31","author":"LH Vorland","year":"1999","unstructured":"Vorland LH, Osbakk SA, Perstqlen T et al (1999) Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus. Scand J Infect Dis 31:173\u2013177","journal-title":"Scand J Infect Dis"},{"key":"1739_CR33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1128\/AAC.43.5.1111","volume":"43","author":"YQ Xiong","year":"1999","unstructured":"Xiong YQ, Yeaman MR, Bayer AS (1999) In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother 43:1111\u20131117","journal-title":"Antimicrob Agents Chemother"},{"key":"1739_CR34","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00018-011-0710-x","volume":"68","author":"AT Yeung","year":"2011","unstructured":"Yeung AT, Gellatly SL, Hancock REW (2011) Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci 68:2161\u20132176","journal-title":"Cell Mol Life Sci"},{"key":"1739_CR35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.actbio.2013.08.043","volume":"10","author":"X Zhu","year":"2014","unstructured":"Zhu X, Dong N, Wang ZY et al (2014) Design of imperfectly amphipathic \u03b1-helical antimicrobial peptides with enhanced cell selectivity. Acta Biomater 10:244\u2013257","journal-title":"Acta Biomater"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-014-1739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11274-014-1739-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-014-1739-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T01:18:20Z","timestamp":1650158300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11274-014-1739-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,16]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1739"],"URL":"https:\/\/doi.org\/10.1007\/s11274-014-1739-4","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,16]]}}}